| Name | Tariff | BNF Sub Paragraph | |
| Nicorandil 10 mg tab Pack of 60 | £1.74 | Other Antianginal Drugs | |
| Nicorandil 20 mg tab Pack of 60 | £2.38 | Other Antianginal Drugs | |
| Ivabradine 7.5 mg tablets Pack of 56 | £3.82 | Other Antianginal Drugs | |
Can be initiated in primary care following specialist recommendation |
| Ivabradine 5 mg tablets Pack of 56 | £12.53 | Other Antianginal Drugs | |
Can be initiated in primary care following specialist recommendation |
| Ivabradine 2.5 mg tablets Pack of 56 | £42.52 | Other Antianginal Drugs | |
Can be initiated in primary care following specialist recommendation |
| Ranolazine (Ranexa) 375 mg tab Pack of 60 | £47.05 | Other Antianginal Drugs Other Antianginal Drugs | |
Ranolazine, as a non formulary drug, has a limited place in the patient pathway for the management of stable angina. Ranolazine would be considered for patients already on beta-blocker and/or calcium channel blocker and then only if long acting nitrate, nicorandil and ivabradine are not suitable or ineffective. Hence ranolazine is to be considered a non-formulary drug that should be specialist initiated, and where transfer of prescribing to primary care requires the appropriate transfer of information on dosing, cautions (including interactions with commonly prescribed drugs), and contraindications. |
| Ranolazine (Ranexa) 500 mg tab Pack of 60 | £47.13 | Other Antianginal Drugs Other Antianginal Drugs | |
Ranolazine, as a non formulary drug, has a limited place in the patient pathway for the management of stable angina. Ranolazine would be considered for patients already on beta-blocker and/or calcium channel blocker and then only if long acting nitrate, nicorandil and ivabradine are not suitable or ineffective. Hence ranolazine is to be considered a non-formulary drug that should be specialist initiated, and where transfer of prescribing to primary care requires the appropriate transfer of information on dosing, cautions (including interactions with commonly prescribed drugs), and contraindications. |
| Ranolazine (Ranexa) 750 mg tab Pack of 60 | £47.13 | Other Antianginal Drugs Other Antianginal Drugs | |
Ranolazine, as a non formulary drug, has a limited place in the patient pathway for the management of stable angina. Ranolazine would be considered for patients already on beta-blocker and/or calcium channel blocker and then only if long acting nitrate, nicorandil and ivabradine are not suitable or ineffective. Hence ranolazine is to be considered a non-formulary drug that should be specialist initiated, and where transfer of prescribing to primary care requires the appropriate transfer of information on dosing, cautions (including interactions with commonly prescribed drugs), and contraindications. |
| Trimetazidine 35 MG MR Tablets Pack of 1 | - | Other Antianginal Drugs | |